Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research Protocol for Evaluating the Diagnostic Utility of SAA, Procalcitonin, Presepsin, CRP, and Routine Blood Biomarkers in Adult Burn Patients With Sepsis in the Intensive Care Unit

NCT07126574 is registered in ClinicalTrials.gov with Dohern Kym as lead sponsor.

NCT NCT07126574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07126574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research Protocol for Evaluating the Diagnostic Utility of SAA, Procalcitonin, Presepsin, CRP, and Routine Blood Biomarkers in Adult Burn Patients With Sepsis in the Intensive Care Unit
Lead sponsor
Dohern Kym
Phase
Observational
Overall status
Enrolling by invitation
Start date
August 15, 2025
Completion date
October 31, 2026
Enrollment
165 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

burns involving 20% or more of body surface, sepsis - to reduce mortality in the intensive care unit